CURAGEN CORPORATION

Ajouter à une liste

Instrument Inactif

Communiqués CuraGen Corporation

Actions

US23126R1014

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

Communiqués

31/07/09	CURAGEN CO USD0.01 : CuraGen Reports Second Quarter 2009 Financial Results	PR
30/11/-1	CURAGEN : Reports Third Quarter 2008 Financial Results	PR
30/11/-1	CURAGEN : to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008	PR
30/11/-1	CURAGEN : Corporation Receives Notification from NASDAQ	PR
30/11/-1	CURAGEN : Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE	PR
30/11/-1	CURAGEN : to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference	PR
30/11/-1	CURAGEN : Corporation Regains NASDAQ Listing Compliance	PR
30/11/-1	Curagen : CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million	PR
30/11/-1	Curagen : CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million	PR
30/11/-1	Curagen : CuraGen Reports First Quarter 2008 Financial Results	PR
30/11/-1	Curagen : CuraGen Sells Ownership of Belinostat to TopoTarget A/S	PR
30/11/-1	Curagen : CuraGen to Present at the BIO CEO & Investor Conference	PR
30/11/-1	Curagen : CuraGen Reports Fourth Quarter and Year End 2007 Financial Results	PR
30/11/-1	CURAGEN : Announces Board of Director Changes	PR
30/11/-1	CURAGEN : CuraGen's Board of Directors to Evaluate Strategic Initiatives	PR
30/11/-1	CURAGEN : Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009	PR
30/11/-1	CURAGEN : to Present at the Rodman & Renshaw Annual Global Investment Conference	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Google vous laisse choisir vos sources.

G Google

Choisissez Zonebourse

G Google

Choisissez Zonebourse